Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRON-DEP: Intravenous Versus Oral Iron for Postpartum Depression After Caesarean
NCT06833788Phase 4Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in postpartum depression (PPD), iron deficiency anemia (IDA), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2025; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
postpartum depression (PPD)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06833788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06833788.